Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the antiobesity market size evolved in recent years?

The market size for antiobesity initiatives has seen a rapid expansion in the past few years. From a value of $3.74 billion in 2024, it is projected to increase to $4.15 billion in 2025, with a compound annual growth rate (CAGR) of 11.1%. This significant growth in the previous period can be traced back to factors such as rising prevalence of obesity, increased awareness and education, changes in lifestyle, and government policies.

What are the predictions for the antiobesity market size in the coming years?

Predictions for the antiobesity market forecast a swift expansion in the coming years, reaching a size of $6.08 billion by 2029 with a compound annual growth rate (CAGR) of 10.0%. The projected growth within this period can be credited to market diversification and globalization. Key trends expected to shape the market within this forecast period encompass research and development efforts, patient-focused strategies, insurance coverage improvements, technological innovations, the integration of digital health and telemedicine, the introduction of new drug therapies, advancements in bariatric surgery, the availability of over-the-counter (OTC) solutions, behavioural modification strategies, and the uptake of nutritional and weight management apps.

Get your antiobesity market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3403&type=smp

What key factors are fueling the growth of the antiobesity market?

The significant global health issue of obesity cannot be ignored. The World Obesity Atlas, a UK-based obesity institution, revealed in May 2022 that the global rate of obesity is on the rise each year. They project that by 2030, over 1 billion individuals worldwide will be affected by obesity. This surge can be traced back to the greater intake of processed and unhealthy foods, inability to engage in physical exercise, and a lack of consciousness about obesity-related hazards. Therefore, the increasing need for anti-obesity drugs is a given in the future, propelling the growth of this market.

How is the global antiobesity market divided into key segments?

The antiobesity market covered in this report is segmented –

1) By Drug Class: Peripherally Acting Anti-Obesity Drugs, Centrally Acting Anti-Obesity Drugs

2) By Type: Prescription Drugs (Rx), OTC Drugs

3) By Medication: Monotherapies, Polytherapies

Subsegments:

1) By Peripherally Acting Anti-Obesity Drugs: Orlistat, Lorcaserin

2) By Centrally Acting Anti-Obesity Drugs: Phentermine, Topiramate, Naltrexone-Bupropion Combination, Liraglutide

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3403&type=smp

Who are the key firms paving the way for growth in the antiobesity market?

Major companies operating in the antiobesity market include F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Novartis International AG, Viking Therapeutics Inc., Structure Therapeutics Inc., Gelesis Inc., Sanofi S.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Limited, Allergan Aesthetics, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd., Cadila Healthcare Ltd., Intas Pharmaceuticals Ltd., Wockhardt Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd.

Which trends are expected to transform the antiobesity market?

Leading firms in the anti-obesity drugs market are putting their focus on creating new products such as Mounjaro (tirzepatide), in order to deliver dependable services to their clients. Utilized as an anti-obesity medication, Mounjaro (tirzepatide) is effective for treating adults who are battling obesity or overweight issues along with weight-related health complexities. In October of 2022, American pharmaceutical giant, Eli Lilly and Company, rolled out Mounjaro (tirzepatide), which received approval as a fast track designation treatment from the US-based federal agency, the Food and Drug Administration (FDA). Mounjaro (tirzepatide) is an injectable variant of an anti-obesity drug designed to assist those grappling with obesity in meeting their weight loss objectives. It is prescribed for adults with type 2 diabetes, in conjunction with a proper diet and exercise regimen, to regulate their blood sugar (glucose) levels.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3403

What regions are contributing significantly to the growth of the antiobesity market?

North America was the largest region in the anti-obesity market in 2023. Middle East is expected to be the fastest-growing region in the antiobesity market. The regions covered in the antiobesity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Hormonal Contraceptives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Organ-On-Chip Global Market Opportunities And Strategies To 2021

https://www.thebusinessresearchcompany.com/report/organ-on-chip-market

Medical Foods Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-foods-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: